HIGH-RISK MYELODYSPLASTIC SYNDROMES

Clinical trials for HIGH-RISK MYELODYSPLASTIC SYNDROMES explained in plain language.

Never miss a new study

Get alerted when new HIGH-RISK MYELODYSPLASTIC SYNDROMES trials appear

Sign up with your email to follow new studies for HIGH-RISK MYELODYSPLASTIC SYNDROMES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug added to transplant could stop blood Cancer's return

Disease control Recruiting now

This study is testing if adding a drug called venetoclax to the standard pre-transplant chemotherapy improves outcomes for people with high-risk acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). About 138 patients aged 12-60 will be randomly assigned to receive eit…

Matched conditions: HIGH-RISK MYELODYSPLASTIC SYNDROMES

Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

HIGH-RISK MYELODYSPLASTIC SYNDROMES

Get alerted when new HIGH-RISK MYELODYSPLASTIC SYNDROMES trials appear

New drug added to transplant could stop blood Cancer's return